Eczema drug shows promise in repairing skin barrier
Disease control
Completed
This study looked at how the drug abrocitinib affects the skin barrier in 20 adults with moderate to severe atopic dermatitis (eczema). Researchers measured water loss from the skin and changes in skin-related genes at 2 and 12 weeks. The goal was to see if the treatment helps re…
Sponsor: Prof. Dr. Stephan Weidinger • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC